Latest Trends in Cancer Therapy Applying Viral Vectors

References

• Lundstrom K . New era in gene therapy . In : Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies . SinghM, SalnikovaM ( Eds ). Elsevier, CA, USA, 13 – 37 ( 2015 ).
   Google Scholar
• Martinez T , WrightN, Lopez-FragaMet al. Silencing human genetic diseases with oligonucleotide-based therapies . Hum. Genet.132, 481 – 493 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ramirez-Montagut T . Cancer vaccines . In : Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies . SinghM, SalnikovaM ( Eds ). Elsevier, CA, USA, 365 – 388 ( 2015 ).
   Google Scholar
• Lundstrom K . Nanocarriers for the delivery of peptides and proteins . In : Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines . JorgensenL, Moerck NielsenH ( Eds ). John Wiley & Sons, Ltd., Chichister, UK, 193 – 205 ( 2009 ).
   Google Scholar
• Lundstrom K , BoulikasT . Viral and non-viral vectors in gene therapy: technology development and clinical trials . Technol. Cancer Res. Treatment.2, 471 – 485 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Raper SE , ChirmuleN, LeeFSet al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer . Mol. Genet. Metab.80, 148 – 158 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• McCormack MP , RabbittsTH . Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency . N. Engl. J. Med.350, 913 – 922 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S , GarrigueA, WangGPet al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 . J. Clin. Invest.118, 3132 – 3142 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lin Y , ZhangH, LiangJet al. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers . Proc. Natl Acad. Sci. USA111, E4504 – E4512 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lin E , NemunaitisJ . Oncolytic viral therapies . Cancer Gene Ther.11, 643 – 664 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Schiedner G , MorralN, ParksRSet al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity . Nat. Genet.18, 180 – 183 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Wang F , WangZ, TianHet al. Biodistribution and safety assessment of bladder cancer specific oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice . Curr. Gene Ther.12, 67 – 76 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fukazawa T , MatsuokaJ, YamatsujiTet al. Adenovirus-mediated cancer gene therapy and virotherapy (review) . Int. J. Mol. Med.25, 3 – 10 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• White KM , AlbaR, ParkerALet al. Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile . J. Cardiothorac. Surg.8, 183 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liu Z , KeF, DuanCet al. Mannan-conjugated adenovirus enhanced gene therapy effects on murine hepatocellular carcinoma in vitro and in vivo . Bioconjug. Chem.24, 1387 – 1397 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Luo J , DengZ-L, LuoXet al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system . Nat. Protocols2, 1236 – 1247 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wei Q , FanJ, LiaoJet al. Engineering the rapid adenovirus production and amplification (RAPA) cell line to expedite the generation of recombinant adenoviruses . Cell Physiol. Biochem.41, 2383 – 2396 ( 2017 ).
   PubMedGoogle Scholar
• Matthews KS , AlvarezRD, CurielDT . Advancements in adenoviral-based virotherapy for ovarian cancer . Adv. Drug Deliv. Rev.61, 836 – 841 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ekblad M , HaldenG . Adenovirus-based therapy for prostate cancer . Curr. Opin. Mol. Ther.12, 421 – 431 ( 2009 ).
   Google Scholar
• Fu YJ , DuJ, YangRJet al. Potential adenovirus-mediated gene therapy of glioma cancer . Biotechnol. Lett.32, 11 – 18 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhangBC, ZhangARet al. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer . Oncol. Rep.30, 1989 – 1995 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Choi JW , LeeJS, KimSW . Evolution of oncolytic adenoviruses for cancer treatment . Adv. Drug Deliv. Rev.64, 720 – 729 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Young BA , SpencerJF, YingBet al. The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcuatenous Syrian hamster tumors . Cancer Gene Ther.20, 521 – 530 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fujiwara T . A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer . Acta Med. Okoyama65, 151 – 162 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Shapira S , ShapiraA, KazanovDet al. Selective eradication of cancer cells by delivery of adenovirus-based toxins . Oncotarget 78 ( 24 ), 38581 – 38591 ( 2017 ).
   PubMedGoogle Scholar
• Zhou W , DaiS, ZhuHet al. Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer . Gene Ther.24, 199 – 207 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Chen J , GaoP, YuanSet al. Oncolytic adenovirus complexes coated with lipids and calcium phosphate for cancer therapy . ACS Nano10, 11548 – 11560 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Samulski RJ , MuzyckaN . AAV-mediated gene therapy for research and therapeutic purposes . Annu. Rev. Virol.1, 427 – 451 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Park K , KimWJ, ChoYHet al. Cancer gene therapy using adeno-associated virus vectors . Front. Biosci.13, 2653 – 2659 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mingozzi F , HighKA . Immune responses to AAV vectors: overcoming barriers to successful gene therapy . Blood122, 23 – 36 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Grieger JC , SamulskiRJ . Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps . J. Virol.79, 9933 – 9944 .
   PubMed Web of Science ®Google Scholar
• Shih CS , LaurieN, HolzmacherJet al. AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models . Neuromolecular Med.11, 43 – 52 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lu L , LuoST, ShiHSet al. AAV2-mediated gene transfer of VEGF-Trap with potent suppression of primary breast tumor growth and spontaneous pulmonary metastases by long-term expression . Oncol. Rep.28, 1332 – 1338 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ling C , LuY, ChengBet al. High efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors . J. Vis. Exp.22, 2538 ( 2011 ).
   Google Scholar
• Yuan L , ZhaoH, ZhangLet al. The efficacy of combination therapy using adeno-associated virus co-expression of apoptin and interleukin-24 on hepatocellular carcinoma . Tumour Biol.34, 3027 – 3034 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Steele JC , Di PasqualeG, RamloganCAet al. Oral vaccination with adeno-associated virus vectors expressing the Neu inhibitis the growth of murine breast cancer . Mol. Ther.21, 680 – 687 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang YG , HuangPP, ZhangRet al. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma . World J. Gastroenterol.22, 326 – 337 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Su H , ChangJC, XuSMet al. Selective killing of AFP positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene . Hum. Gene Ther.7, 463 – 470 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• He LF , WangYG, XiaoTet al. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter . Cancer Lett.286, 196 – 205 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Sun A , TangJ, TerranovaPFet al. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study . Int. J. Cancer126, 764 – 774 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Crommentujn MH , KantarR, NoskeDPet al. Systematically administered AAV9-strain combats invasive glioblastoma in a patient-derived orthotopic xenograft model . Mol. Ther. Oncolytics3, 16017 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Srivastava A , CarterBJ . AAV infection: protection from cancer . Hum. Gene Ther.28, 323 – 327 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Epstein AL , MarconiP, ArgnaniRet al. HSV-1 derived recombinant and amplicon vectors for gene transfer and gene therapy . Curr. Gene Ther.5, 445 – 458 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Jerusalinsky D , BaezMV, EpsteinAL . Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases . J. Physiol. Paris106, 2 – 11 ( 2012 ).
   PubMedGoogle Scholar
• Meshii N , TakahashiG, OkunagaSet al. Enhancement of systemic tumor immunity for squamous cell carcinoma cells from oncolytic herpes simplex virus . Cancer Gene Ther.20, 493 – 498 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li JM , KaoKC, LiLFet al. MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small lung cancer cells . Virol. J.10, 241 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li H , NakashimaH, DeckleverTDet al. HSV-NIS, an oncolytic herpes simplex virus type 1 encoding the human sodium iodine symporter for preclinical prostate cancer radiovirotherapy . Cancer Gene Ther.20, 478 – 485 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen CY , WangPY, HutzenBet al. Cooperation of oncolytic herpes virotherapy and blockade in murine rhabdomyosarcoma models . Sci. Rep.7, 2396 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Yin L , ZhaoC, HanJet al. Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo . Ther. Clin. Risk Manag.13, 117 – 130 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wang X , LiuS, ZhouZet al. A herpes simplex virus type 2-encoded microRNA promotes tumor cell metastasis by targeting suppressor of cytokine signaling 2 in lung cancer . Tumour Biol.39, 1010428317701633 ( 2017 ).
   Google Scholar
• Cavazzano-Calvo M , Hacein-BeyS, de Saint BasilleGet al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease . Science288, 669 – 672 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Hu WS , PathakVK . Design of retroviral vectors and helper cells for gene therapy . Pharmacol. Rev.52, 493 – 511 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Khare PD , LiaoS, HiroseYet al. Tumor growth suppression by a retroviral vector displaying scFv antibody to CEA and carrying the iNOS gene . Anticancer Res.22, 2443 – 2446 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Li F , GuoY, HanLet al. In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus . Oncol. Lett.4, 1254 – 1258 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Schambach A , MorganM . Retroviral vectors for cancer gene therapy . Recent Results Cancer Res.209, 17 – 35 ( 2016 ).
   PubMedGoogle Scholar
• Vigna E , NaldiniL . Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy . J. Gen. Med.2, 308 – 316 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Kay MA , GloriosoJC, NaldiniL . Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics . Nat. Med.7, 33 – 40 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Ren B , O’BrienBA, ByrneMRet al. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy . J. Gen. Med.15, 28 – 41 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chung J , RossiJJ, JungU . Current progress and challenges in HIV gene therapy . Future Virol.6, 1319 – 1328 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Deglon N , AebischerP . Lentiviruses as vectors for CNS diseases . Curr. Top. Microbiol. Immunol.261, 191 – 209 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Guo SW , CheHM, LiWZ . Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma . Cancer Sci.102, 1038 – 1044 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ravet L , LulkaH, GrossFet al. Using lentiviral vectors for efficient pancreatic cancer gene therapy . Cancer Gene Ther.17, 315 – 324 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Xiao L , JooKI, LimMet al. Dendritic cell-directed vaccination with a lentivector PSCA for prostate cancer in mice . PLoS ONE7, e48866 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang YW , NiuJ, LuXet al. Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studies . J. Hepatol.58, 502 – 508 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen YS , LiHR, MiaoYet al. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1-phase cell cycle arrest . Int. J. Clin. Exp. Pathol.5, 796 – 805 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Minai-Tehrani A , ChangSH, KwonJTet al. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tomrigenesis in K-ras (LA1) mice . Cell Oncol. (Dordr.)36, 15 – 26 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Seidlits SK , GowerRM, ShepardJAet al. Hydrogels for lentiviral gene delivery . Expert Opin. Drug Deliv.10, 499 – 509 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yolamanova M , MeierC, ShaytanAKet al. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses . Nat. Nanotechnol.8, 130 – 136 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ranzani M , CesanaD, BartolomaeCCet al. Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer . Nat. Methods10, 155 – 161 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Tian L , LiuJ, XiaGHet al. RNAi-mediated knockdown of MCM7 gene on CML cells and its therapeutic potential for leukemia . Med. Oncol.34, 21 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Li R , YangHQ, HiHLet al. Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells . Int. J. Oncol.50, 15 – 22 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Yan F , WangX, ZhuMet al. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth . Oncol. Rep.36, 2793 – 2799 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Lundstrom K . Biology and application of alphaviruses in gene therapy . Gene Ther.12, S92 – S97 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Liljestrom P , GaroffH . A new generation of animal cell expression vectors based on the Semliki Forest virus replicon . Biotechnology9, 1356 – 1361 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Xiong C , LevisR, ShenPet al. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells . Science243, 1188 – 1191 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Davis NL , WillisLV, SmithJFet al. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant . Virology171, 189 – 204 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Ying H , ZaksTZ, WangRFet al. Cancer therapy using a self-replicating RNA vaccine . Nat. Med.5, 823 – 827 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Leitner WW , HwangLN, de VeerMJet al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways . Nat. Med.9, 33 – 39 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Murphy AM , Morris-DownesMM, SheahanBJet al. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles . Gene Ther.7, 1477 – 1482 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Asselin-Paturel C , LassauN, GuinebretiereJMet al. Transfer of the murine interleukin-12 in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography . Gene Ther.6, 606 – 615 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Avogadri F , MerghoubT, MaughanMFet al. Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity . PLoS ONE5, e12670 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Velders MP , McElhineyS, CassettiMCet al. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA . Cancer Res.61, 7861 – 7867 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Colmenero P , LiljeströmP, JondalM . Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene . Gene Ther.6 ( 10 ), 1728 – 1733 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Moran TP , BurgentsJE, LongBet al. Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice . Vaccine25, 6604 – 6612 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yin X , WangW, ZhuXet al. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis . Biochem. Biophys. Res. Comm.465, 239 – 244 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Draghiciu O , BoermaA, HoogeboomBNet al. A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development . Oncoimmunology4, e1029699 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lyons JA , SheahanBJ, GalbraithSEet al. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice . Gene Ther.14, 503 – 513 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vähä-Koskela MJ , KallioJP, JanssonLCet al. Oncolytic capacity of attenuated replicative Semliki Forest virus in human melanoma xenografts in severe combined immunodeficient mice . Cancer Res.66, 7185 – 7194 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ketola A , HinkkanenA, YongabiFet al. Oncolytic Semliki Forest virus vector as a novel candidate against unresectabe osteosarcoma . Cancer Res.68, 8342 – 8350 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Määttä AM , MäkinenK, KetolaAet al. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer . Int. J. Cancer123, 1704 – 1711 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ylosmaki E , MartikainenM, HinkkanenAet al. Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting . J. Virol.87, 335 – 344 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Autio KP , RuotsalainenJJ, AnttilaMOet al. Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles . BMC Vet. Res.11, 170 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chen CH , HuangGL, TuYQet al. Dual specific antitumor effects of Semliki Forest virus-based DNA vector carrying suicide Escherichia coli purine nucleoside phosphorylase gene via Salmonella . Int. J. Oncol.42, 2009 – 2018 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lin Y , ZhangH, LiangJet al. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers . Proc. Natl Acad. Sci. USA111, E4504 – E4512 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tseng JC , LevinB, HurtadoAet al. Systemic tumor targeting and killing by Sindbis viral vectors . Nat. Biotechnol.22, 70 – 77 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Madoz JR , PrietoJ, SmerdouC . Biodistribution and tumor infectivity of Semliki Forest virus vectors in mice: effects of re-administration . Mol. Ther.15, 2164 – 2171 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lundstrom K , BoulikasT . Breakthrough in cancer therapy: encapsulation of drugs and viruses . Curr. Drug Discov.11, 19 – 23 ( 2002 ).
   Google Scholar
• Pijlman GP , SuhrbierA, KhromykhAA . Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications . Exp. Opin. Biol. Ther.6, 134 – 145 ( 2006 ).
   Web of Science ®Google Scholar
• De Felipe F . Skipping the co-expression problem: the new 2A ‘CHYSEL’ technology . Genet. Vaccines Ther.2, 13 ( 2004 ).
   PubMedGoogle Scholar
• Shi PY , TilgnerM, LoMK . Construction and characterization of subgenomic replicons of New York strain of West Nile virus . Virology296, 219 – 233 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Scholle I , GirardYA, ZhaoQet al. Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors . J. Virol.78, 11605 – 11614 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Molenkamp R , KooiEA, LucassenMAet al. Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins . J. Virol.77, 1644 – 1648 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Jones CT , PatkarCG, KuhnRJ . Construction and applications of yellow fever virus replicons . Virology331, 247 – 259 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Jones M , DavidsonA, HibbertLet al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression . J. Virol.79, 5414 – 5420 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Pang X , ZhangM, DaytonAI . Development of Dengue virus Type 2 replicons capable of prolonged expression in host cells . BMC Microbiol.1, 18 ( 2001 ).
   PubMedGoogle Scholar
• Gherke R , EckerM, AberleSWet al. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line . J. Virol.77, 8924 – 8933 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Hayasaka D , YoshiiK, UekiTet al. Sub-genomic replicons of Tick-borne encephalitis virus . Arch. Virol.149, 1245 – 1256 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hoang-Le D , SmeenkL, AnrakuIet al. A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy . Gene Ther.16, 190 – 199 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lyles DS , RupprechtCE . Rhabdoviridiae . In : Fields’ Virology . KnipeDM, HowleyPM ( Eds ). Wolters Kluwer, Alphen aan den Rijn, The Netherlands, 1364 – 1408 ( 2007 ).
   Google Scholar
• Osakada F , CallawayEM . Design and generation of recombinant rabies virus vectors . Nat. Protoc.8, 1583 – 1601 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ito N , Takayama-ItoM, YamadaKet al. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system . Microbiol. Immunol.47, 613 – 617 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• An H , KimGN, KangCY . Genetically modified VSV(NJ) vector is capable of accommodating a large foreign gene insert and allows high level gene expression . Virus Res.171, 168 – 177 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Murphy AM , BesmerDM, Moerdyk-SchauweckerMet al. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma . J. Virol.86, 3073 – 3087 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hastie E , BesmerDM, ShahNRet al. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive of MUC1-null pancreatic ductal adenocarcinoma . J. Virol.87, 10283 – 10294 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hastie E , GrdzelishviliVZ . Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer . J. Gen. Virol.93, 2529 – 2545 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Felt SA , Moerdyk-SchauweckerMJ, GrdzelishviliVZ . Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus . Virology474, 163 – 173 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Radecke F , SpielhoferP, SchneiderHet al. Rescue of measles viruses from cloned DNA . EMBO J.14, 5773 – 5784 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Msaouel P , IankovID, DispenzieriAet al. Attenuated oncolysis measles virus strains as cancer therapeutics . Curr. Pharm. Biotechnol.13, 1732 – 1741 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Grote D , RussellSJ, CornuTIet al. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice . Blood97, 3746 – 3754 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Hasegawa K , PhamL, O’ConnorMKet al. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter . Clin. Cancer Res.12, 1868 – 1875 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Paraskevakou G , AllenC, NakamuraTet al. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas . Mol. Ther.15, 677 – 686 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• McDonald CJ , ErlichmanC, IngleJNet al. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer . Breast Cancer Res. Treat.99, 177 – 184 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Msaouel P , IankovID, AllenCet al. Engineered measles virus as a novel oncolytic therapy against prostate cancer . Prostate69, 82 – 91 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Csatary LK , MossRW, BeuthHet al. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MHT-68/H) . Anticancer Res.19, 635 – 638 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Zhao L , LiuH . Newcastle disease virus: a promising agent for tumor immunotherapy . Clin. Exp. Pharmacol. Physiol.39, 725 – 730 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Niu Z , BaiF, SunTet al. Recombinant Newcastle disease virus expressing IL15 demonstrates promising antitumor efficiency in melanoma model . Technol. Cancer Res. Treat.14, 607 – 615 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chai Z , ZhangP, FuFet al. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer . Virol. J.11, 84 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kumar R , TiwariAK, ChaturvediUet al. Velogenic Newcastle disease virus as an oncolytic virotherapeutics; in vitro characterization . Appl. Biochem. Biotechnol.167, 2005 – 2022 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wu Y , HeJ, AnYet al. Recombinant Newcastle disease virus (NDV/ANH-IL-2) expressing human IL-2 as a potential candidate suppresses growth of hepatoma therapy . J. Pharmacol. Sci.132, 24 – 30 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Cheng X , WangW, XuQet al. Genetic modification of onbcolytic Newcastle disease virus for cancer therapy . J. Virol.90, 5343 – 5352 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kwak H , HonigH, KaufmannHL . Poxviruses as vectors for cancer immunotherapy . Curr. Opin. Drug Discov. Devel.6, 161 – 168 ( 2003 ).
   PubMedGoogle Scholar
• Zeh HJ , BartlettDL . Development of a replication-selective oncolytic proxvirus for the treatment of human cancers . Cancer Gene Ther.9, 1001 – 1012 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Mastrangelo MJ , LattimeEC . Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors . Cancer Gene Ther.9, 1013 – 1021 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Chen B , TimiryasovaTM, HaghighatPet al. Low-dose vaccinia virus-mediated cytokine gene therapy of glioma . J. Immunother.24, 46 – 57 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Ehrig K , KilincMO, ChenNGet al. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68 . J. Transl. Med.11, 79 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chernichenko N , LinkovG, LiPet al. Oncolytic vaccinia virus therapy of salivary gland carcinoma . JAMA Otolaryngol. Head Neck Surg.139, 173 – 182 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Patil SS , GentschevI, AdelfingerMet al. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-h109 expressing an anti-VEGF single-chain antibody . PLoS ONE7, e47472 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Brun J , MahoneyDJ, Le BoeufFet al. Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum . Int. J. Cancer132, 726 – 731 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• He S , LiP, ChenCHet al. Effective oncolytic vaccinia therapy for human sarcomas . J. Surg. Res.175, e53 – e60 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Haddad D , ChenN, ZhangQet al. A novel genetically modified vaccinia virus in experimental models is effective against a wide range of human cancers . Ann. Surg. Oncol.19 ( Suppl. 3 ), S665 – S674 ( 2012 ).
   PubMedGoogle Scholar
• O’Reilly DR . Use of baculovirus expression vectors . Methods Mol. Biol.62, 235 – 246 ( 1997 ).
   PubMedGoogle Scholar
• Kost TA , CondreayJP . Recombinant baculoviruses as mammalian cell gene-delivery vectors . Trends Biotechnol.20, 173 – 180 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Paul A , JardinBA, KulamarvaAet al. Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression and in vitro characterization . Mol. Biotechnol.45, 129 – 139 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Luo WY , ShihYS, LoWHet al. Baculovirus virus vectors for antiangiogenesis-based cancer gene therapy . Cancer Gene Ther.18, 637 – 645 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Swift SL , RiveraGC, DussuptVet al. Evaluating baculovirus as a vector for human prostate cancer therapy . PLoS ONE8, e65557 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhao Y , LamDH, YangJet al. Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors . Gene Ther.19, 189 – 200 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ang WX , ZhaoY, KwangTet al. Locale immune stimulation by intravesical installation of baculovirus to enable bladdet cancer therapy . Sci. Rep.6, 27455 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Lykhova AA , KudryavetsYI, StrokovskaLIet al. Suppression of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus vector . Cytokine71, 318 – 326 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ginn SL , AlexanderIE, EdelsteinMLet al. Gene therapy clinical trials worldwide 2012 – an update . J. Gene Med.15, 65 – 77 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gene Therapy Clinical Trials Worldwide – Abedia . www.abedia.com/wiley/countries.php .
   Google Scholar
• Keeler AM , El MallahMK, FlotteTR . Gene therapy 2017: progress and future directions . Clin. Transl. Sci.10 ( 4 ), 242 – 248 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Räty JK , PikkarainenJT, WirthTet al. Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications . Curr. Mol. Pharmacol.1, 13 – 23 ( 2008 ).
   PubMedGoogle Scholar
• Liu T-C , KimD . Gene therapy progress and prospects cancer: oncolytic viruses . Gene Ther.15, 877 – 884 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Fukuhara H , InoY, TodoT . Oncolytic virus therapy: a new era of cancer treatment at dawn . Cancer Sci.107, 1373 – 1379 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kaufman HL , KimDW, DeRaffeleGet al. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma . Ann. Surg. Oncol.17, 718 – 730 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Heo J , ReidT, RuoLet al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer . Nat. Med.19, 329 – 336 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ino Y , TodoT . Clinical development of a third-generation HSV-1 (G47Δ) for malignant glioma . Gene Ther. Regul.5, 101 – 111 ( 2010 ).
   Google Scholar
• Ramesh N , GeY, EnnistDLet al. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor – armed oncolytic adenovirus for the treatment of bladder cancer . Clin. Cancer Res.12, 305 – 313 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Gollamudi R , GhalibMH, DesaiKKet al. REO-001: intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients in advanced solid tumors . Invest. New Drugs28, 641 – 649 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Straus JH , StraussEG . The alphaviruses: gene expression, replication and evolution . Microbiol. Rev.58, 491 – 562 ( 1994 ).
   PubMedGoogle Scholar
• Shah PP , HutchinsonLE, KakarSS . Emerging roles of miRNAs in diagnosis and treatment of various diseases including ovarian cancer . J. Ovarian Res.2, 11 ( 2009 ).
   PubMed Web of Science ®Google Scholar